Cargando…

Small Leucine-Rich Proteoglycan PODNL1 Identified as a Potential Tumor Matrix-Mediated Biomarker for Prognosis and Immunotherapy in a Pan-Cancer Setting

The podocan-like protein 1 (PODNL1), an important member of the small leucine-rich proteoglycans (SLRP) family, is a crucial component of the tumor microenvironment (TME). But its prognostic values and the role in the TME have not been systematically estimated in a pan-cancer setting. Targeting PODN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Geyang, Sun, Yue, Wei, Rui, Xi, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378008/ https://www.ncbi.nlm.nih.gov/pubmed/37504302 http://dx.doi.org/10.3390/cimb45070386

Ejemplares similares

Small Leucine-Rich Proteoglycans (SLRPs) in the Retina
por: Low, Shermaine W. Y., et al.
Publicado: (2021)

The matricellular functions of small leucine-rich proteoglycans (SLRPs)
por: Merline, Rosetta, et al.
Publicado: (2009)

Small Leucine-Rich Proteoglycans in Skin Wound Healing
por: Pang, Xiaoxiao, et al.
Publicado: (2020)

Usurped SLRPs: novel arthritis biomarkers exposed by catabolism of small leucine-rich proteoglycans?
por: Flannery, Carl R
Publicado: (2006)

Topological Analysis of Small Leucine-Rich Repeat Proteoglycan Nyctalopin
por: Bojang, Pasano, et al.
Publicado: (2012)

Small leucine rich proteoglycans, a novel link to osteoclastogenesis
por: Kram, Vardit, et al.
Publicado: (2017)

Small leucine-rich proteoglycans in physiological and biomechanical function of bone
por: Hua, Rui, et al.
Publicado: (2021)

Inhibitory Role of the Small Leucine-Rich Proteoglycan Biglycan in Bladder Cancer
por: Niedworok, Christian, et al.
Publicado: (2013)

Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site
por: Monfort, Jordi, et al.
Publicado: (2006)

Correction: Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease 13 - identification of a new biglycan cleavage site
por: Monfort, Jordi, et al.
Publicado: (2013)

Modulation of small leucine-rich proteoglycans (SLRPs) expression in the mouse uterus by estradiol and progesterone
por: Salgado, Renato M, et al.
Publicado: (2011)

Small leucine-rich proteoglycans in atherosclerotic lesions: novel targets of chronic statin treatment?
por: Marzoll, Andrea, et al.
Publicado: (2011)

Structural and functional analysis of two small leucine-rich repeat proteoglycans, fibromodulin and chondroadherin
por: Paracuellos, Patricia, et al.
Publicado: (2017)

The role of Tsukushi (TSK), a small leucine-rich repeat proteoglycan, in bone growth
por: Yano, Kosei, et al.
Publicado: (2017)

Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases
por: Zeng-Brouwers, Jinyang, et al.
Publicado: (2020)

The Small Leucine-Rich Repeat Proteoglycan Biglycan Binds to α-Dystroglycan and Is Upregulated in Dystrophic Muscle
por: Bowe, Mark A., et al.
Publicado: (2000)

Contaminants in commercial preparations of ‘purified’ small leucine-rich proteoglycans may distort mechanistic studies
por: Brown, Sharon J., et al.
Publicado: (2017)

Expression, localization and synthesis of small leucine-rich proteoglycans in developing mouse molar tooth germ
por: Randilini, Angammana, et al.
Publicado: (2020)

The Extracellular Small Leucine-Rich Proteoglycan Biglycan Is a Key Player in Gastric Cancer Aggressiveness
por: Pinto, Filipe, et al.
Publicado: (2021)

Roles of Two Small Leucine-Rich Proteoglycans Decorin and Biglycan in Pregnancy and Pregnancy-Associated Diseases
por: Halari, Chidambra D., et al.
Publicado: (2021)

The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican
por: Berdiaki, Aikaterini, et al.
Publicado: (2023)

PODNL1 promotes cell proliferation and migration in glioma via regulating Akt/mTOR pathway
por: Geng, Yibo, et al.
Publicado: (2020)

Posterior Amorphous Corneal Dystrophy Is Associated with a Deletion of Small Leucine-rich Proteoglycans on Chromosome 12
por: Kim, Michelle J., et al.
Publicado: (2014)

Small leucine-rich proteoglycans (SLRPs) in the endometrium of polycystic ovary syndrome women: a pilot study
por: Simões, Ricardo Santos, et al.
Publicado: (2017)

Expression of minor cartilage collagens and small leucine rich proteoglycans may be relatively reduced in osteoarthritic cartilage
por: Tanaka, Nobuho, et al.
Publicado: (2019)

Small leucine-rich proteoglycans inhibit CNS regeneration by modifying the structural and mechanical properties of the lesion environment
por: Kolb, Julia, et al.
Publicado: (2023)

PODNL1 Methylation Serves as a Prognostic Biomarker and Associates with Immune Cell Infiltration and Immune Checkpoint Blockade Response in Lower-Grade Glioma
por: Noor, Humaira, et al.
Publicado: (2021)

Opticin, a small leucine-rich proteoglycan, is uniquely expressed and translocated to the nucleus of chronic lymphocytic leukemia cells
por: Mikaelsson, Eva, et al.
Publicado: (2013)

Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy
por: Zhang, Jing, et al.
Publicado: (2022)

The Genes Encoding Small Leucine-Rich Proteoglycans Undergo Differential Expression Alterations in Colorectal Cancer, Depending on Tumor Location
por: Solis-Hernandez, Maria Pilar, et al.
Publicado: (2021)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

The small leucine-rich proteoglycan, biglycan, is highly expressed in adipose tissue of Psammomys obesus and is associated with obesity and type 2 diabetes
por: Bolton, Kristy, et al.
Publicado: (2012)

Abstract 15: The Role of Burn Tissue and Denatured Small Leucine Rich Proteoglycans in the Activation of the Toll-like Receptor 4 Pathway
por: Agrawal, Ambika, et al.
Publicado: (2019)

Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response
por: Tong, Wen, et al.
Publicado: (2022)

Extracellular Matrix: Surface Proteoglycans
por: Park, Pyong Woo
Publicado: (2022)

Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
por: Zhao, Qinfei, et al.
Publicado: (2022)

Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy
por: Liu, Jinhui, et al.
Publicado: (2022)

Pan-cancer analysis of ADAMs: A promising biomarker for prognosis and response to chemotherapy and immunotherapy
por: Ma, Bo, et al.
Publicado: (2023)

Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response
por: Zheng, Hong, et al.
Publicado: (2023)

Leucine-rich alpha-2-glycoprotein 1 and angiotensinogen as diagnostic biomarkers for Kawasaki disease
por: Yanagimachi, Masakatsu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_maibhjrd3f4ihu383r40k0ot8c